Elisabeth M Simonin, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypersensitivity | 6 | 2023 | 1102 | 1.990 |
Why?
|
| Horses | 8 | 2023 | 304 | 1.670 |
Why?
|
| Ceratopogonidae | 4 | 2021 | 4 | 1.240 |
Why?
|
| Immunoglobulin E | 7 | 2023 | 1463 | 1.190 |
Why?
|
| Horse Diseases | 3 | 2021 | 57 | 1.130 |
Why?
|
| Monocytes | 3 | 2023 | 2593 | 1.060 |
Why?
|
| Hypersensitivity, Immediate | 2 | 2023 | 337 | 1.010 |
Why?
|
| Receptors, IgE | 2 | 2022 | 389 | 0.830 |
Why?
|
| Allergens | 4 | 2023 | 1320 | 0.540 |
Why?
|
| Herpesvirus 1, Equid | 1 | 2021 | 2 | 0.410 |
Why?
|
| Receptors, Prostaglandin | 1 | 2020 | 57 | 0.360 |
Why?
|
| Strongylida Infections | 1 | 2020 | 46 | 0.360 |
Why?
|
| Insect Bites and Stings | 1 | 2020 | 67 | 0.350 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 4422 | 0.350 |
Why?
|
| Herpesviridae Infections | 1 | 2021 | 277 | 0.350 |
Why?
|
| Plasma Cells | 2 | 2023 | 593 | 0.340 |
Why?
|
| Interleukin-8 | 1 | 2021 | 690 | 0.310 |
Why?
|
| Immunity, Mucosal | 1 | 2021 | 490 | 0.310 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2018 | 122 | 0.300 |
Why?
|
| Antibodies, Monoclonal | 2 | 2021 | 9272 | 0.270 |
Why?
|
| Cricetulus | 2 | 2021 | 818 | 0.260 |
Why?
|
| Basophils | 2 | 2021 | 389 | 0.250 |
Why?
|
| CHO Cells | 2 | 2021 | 1409 | 0.240 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 10179 | 0.230 |
Why?
|
| Receptors, Immunologic | 1 | 2020 | 1423 | 0.230 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 1836 | 0.220 |
Why?
|
| Lymphocytes | 1 | 2020 | 2615 | 0.200 |
Why?
|
| Immunomagnetic Separation | 1 | 2021 | 80 | 0.200 |
Why?
|
| Anaphylaxis | 1 | 2018 | 746 | 0.190 |
Why?
|
| Mast Cells | 1 | 2018 | 1544 | 0.190 |
Why?
|
| Cell Movement | 1 | 2020 | 5216 | 0.150 |
Why?
|
| Interleukin-4 | 1 | 2021 | 1147 | 0.150 |
Why?
|
| Cricetinae | 1 | 2021 | 2475 | 0.150 |
Why?
|
| Animals | 10 | 2023 | 168660 | 0.140 |
Why?
|
| Cloning, Molecular | 1 | 2021 | 4320 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 1 | 2023 | 2009 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2023 | 12066 | 0.120 |
Why?
|
| Up-Regulation | 1 | 2023 | 4221 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 6380 | 0.100 |
Why?
|
| Recombinant Proteins | 2 | 2021 | 6620 | 0.090 |
Why?
|
| Flow Cytometry | 1 | 2021 | 5973 | 0.090 |
Why?
|
| Nippostrongylus | 1 | 2020 | 23 | 0.090 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 5524 | 0.090 |
Why?
|
| Hybridomas | 1 | 2021 | 452 | 0.090 |
Why?
|
| Prostaglandin D2 | 1 | 2020 | 122 | 0.090 |
Why?
|
| Transcription, Genetic | 1 | 2023 | 7719 | 0.080 |
Why?
|
| Adoptive Transfer | 1 | 2020 | 844 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2021 | 19232 | 0.070 |
Why?
|
| Immunization | 1 | 2021 | 1255 | 0.070 |
Why?
|
| Mice | 4 | 2021 | 81154 | 0.070 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 715 | 0.070 |
Why?
|
| Antigens, Surface | 1 | 2020 | 1663 | 0.070 |
Why?
|
| Chemotaxis | 1 | 2018 | 607 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2022 | 15526 | 0.060 |
Why?
|
| Transfection | 1 | 2021 | 5892 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 21824 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 18027 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2020 | 2961 | 0.040 |
Why?
|
| Cytokines | 1 | 2020 | 7324 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2020 | 14563 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10477 | 0.030 |
Why?
|
| Female | 3 | 2021 | 380020 | 0.020 |
Why?
|
| Lung | 1 | 2020 | 9858 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2018 | 11478 | 0.020 |
Why?
|
| Male | 2 | 2021 | 349776 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 16361 | 0.010 |
Why?
|
| Humans | 2 | 2021 | 743811 | 0.010 |
Why?
|